Suchergebnisse - "Lipson, Evan J"

PubPharm (145)

1

Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Schenk, K. | Deutsch, J. | Chandra, S. | +23

2

Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade

enthalten in: Journal of translational medicine | 2024

von Chen, S. | McMiller, T. | Soni, A. | +15

3

Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade

enthalten in: Journal of translational medicine | 2024

von Chen, S. | McMiller, T. | Soni, A. | +15

4

Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade

enthalten in: Journal for immunotherapy of cancer | 2023

von Deutsch, J. | Lai, J. | Schenk, K. | +13

5

Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)

enthalten in: Pigment cell & melanoma research | 2023

von Wei, A. | Chen, L. | Orloff, M. | +26

6

Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma : follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

enthalten in: The Lancet. Oncology | 2023

von Gross, N. | Miller, D. | Khushalani, N. | +24

7

Durable tumor regression and restoration of neurologic function after treatment with anti-PD-1 in patients with functionally unresectable cutaneous squamous cell carcinoma with perineural spread into the cavernous sinus

enthalten in: Journal of neuro-oncology | 2023

von Carey, A. | Warrier, G. | Hoang, J. | +3

8

Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis

enthalten in: Journal of neurosurgery. Spine | 2023

von Lee, E. | Chen, X. | LeCompte, M. | +12

9

Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma : RELATIVITY-047 trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Schadendorf, D. | Tawbi, H. | Lipson, E. | +12

10

Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy : Results From the Phase I/IIa RELATIVITY-020 Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Ascierto, P. | Lipson, E. | Dummer, R. | +19

CommentIn: J Clin Oncol. 2023 May 20;41(15):2691-2694. - PMID 36854080

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]